Train Babcock Advisors’s AbbVie ABBV Stock Holding History

Train Babcock Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$704K	Sell	7,285 -3,095	-30%	-$292K	0.31%	60
2017 Q3	$923K	Sell	10,380 -35	-0.3%	-$2.66K	0.51%	43
2017 Q2	$755K	Sell	10,415 -85	-0.8%	-$5.71K	0.33%	61
2017 Q1	$684K	Sell	10,500 -925	-8%	-$58.2K	0.31%	64
2016 Q4	$716K	Sell	11,425 -1,115	-9%	-$68.1K	0.29%	69
2016 Q3	$791K	Buy	12,540 +110	+0.9%	+$7.12K	0.32%	65
2016 Q2	$769K	Hold	12,430	–	–	0.31%	66
2016 Q1	$710K	Hold	12,430	–	–	0.28%	67
2015 Q4	$737K	Sell	12,430 -480	-4%	-$27.6K	0.28%	72
2015 Q3	$703K	Sell	12,910 -600	-4%	-$39.1K	0.25%	76
2015 Q2	$907K	Sell	13,510 -100	-0.7%	-$6.53K	0.29%	74
2015 Q1	$797K	Sell	13,610 -130	-0.9%	-$7.85K	0.25%	80
2014 Q4	$899K	Buy	13,740 +100	+0.7%	+$6.3K	0.29%	74
2014 Q3	$788K	Sell	13,640 -200	-1%	-$11.1K	0.27%	77
2014 Q2	$781K	Hold	13,840	–	–	0.25%	78
2014 Q1	$712K	Hold	13,840	–	–	0.23%	80
2013 Q4	$732K	Hold	13,840	–	–	0.25%	74
2013 Q3	$619K	Hold	13,840	–	–	0.23%	76
2013 Q2	$572K	Buy	+13,840	New	+$605K	0.22%	73

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Train Babcock Advisors's ABBV Position: Q4 2017 in Review

Train Babcock Advisors reduced its AbbVie (ABBV) stake by 30% in Q4 2017, selling an estimated $292K and leaving 7,285 shares worth $704K. The position accounts for 0.31% of the portfolio, ranked #60.

Train Babcock Advisors first reported a position in ABBV in Q2 2013 and has held it in 19 quarters since. The position peaked at $923K in Q3 2017. 2,001 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

Train Babcock Advisors held 7,285 shares of AbbVie worth $704K as of Q4 2017.
Train Babcock Advisors sold 3,095 AbbVie shares in Q4 2017, an estimated $292K.
AbbVie made up 0.31% of Train Babcock Advisors's portfolio in Q4 2017, its #60 holding.
Train Babcock Advisors first reported a position in AbbVie in Q2 2013 and has held it in 19 quarters since.
Train Babcock Advisors's AbbVie position peaked at $923K in Q3 2017.
2,001 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on Train Babcock Advisors's 13F filing for Q4 2017, filed 10 Jan 2018.